IP Library Granted Patent US 6,936,443
Granted Patent B2
US 6,936,443 · App. 10/286,387 · Granted Aug 30, 2005

Detection and typing of human papillomavirus using PNA probes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,936,443
App. No.
10/286,387
Granted
Aug 30, 2005
Kind
B2
Abstract

The invention provides materials and methods for detection and typing of HPV infection using PNA probes. More specifically, methods are provided for detecting high-risk types of HPV infection with minimal numbers of PNA probes or using PNA probes to selectively amplify only high-risk types of HPV. Novel primer sequences are also provided.

Claims (15)

1. An essentially pure nucleic acid comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO: 9, 10, 12, 13, 17-19 and 21.

2. The nucleic acid of claim 1 , comprising SEQ ID NOS: 9.

3. The nucleic acid of claim 1 , comprising SEQ ID NOS: 10.

4. The nucleic acid of claim 1 , comprising SEQ ID NOS: 12.

5. The nucleic acid of claim 1 , comprising SEQ ID NOS: 13.

6. The nucleic acid of claim 1 , comprising SEQ ID NOS: 17.

7. The nucleic acid of claim 1 , comprising SEQ ID NOS: 18.

8. The nucleic acid of claim 1 , comprising SEQ ID NOS: 19.

9. The nucleic acid of claim 1 , comprising SEQ ID NOS: 21.

10. A method for amplifying a target nucleic acid comprising selecting a primer selected from the group consisting of SEQ ID NOS: 9, 10, 12, 13 17-19 and 21, and amplifying said target nucleic acid.

11. The method of claim 10 , wherein the method comprises a polymerase chain reaction.

12. The method of claim 10 , further comprising selecting a primer selected from the group consisting of SEQ ID NOS: 8 and 16.

13. The method of claim 10 , wherein a target nucleic acid of the amplification is a high risk strain of human papilloma virus.

14. The method of claim 10 , further comprising selecting a probe comprising a nucleic acid analog to block full length amplification of a non-target nucleic acid.

15. The method of claim 13 , wherein the non-target nucleic acid is of a low risk strain of human papilloma virus.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →